Want to join the conversation?
Financial services company $PRI reported 2Q16 net income of $59.3MM or $1.23 per diluted share, up 21% versus $49.2MM or $0.94 per diluted share in 2Q15, helped by higher net premiums. Revenue rose 8% to $379.2MM in the quarter, driven by growth in the Term Life Insurance segment.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.